(Q40485573)

20 September 2017

1 reference

title

Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias (English)

1 reference

20 September 2017

H M Bryson

1

1 reference

20 September 2017

K J Palmer

series ordinal

2

1 reference

20 September 2017

H D Langtry

series ordinal

3

1 reference

20 September 2017

A Fitton

series ordinal

4

1 reference

20 September 2017

1 January 1993

1 reference

20 September 2017

1 reference

20 September 2017

45

1 reference

20 September 2017

1

1 reference

20 September 2017

85-130

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199345010-00008

20 September 2017

0 references

cites work

Propafenone versus amiodarone in field treatment of primary atrial tachydysrhythmias

1 reference

12 December 2020

Propafenone: a promising new antiarrhythmic agent

1 reference

12 December 2020

Comparative electrophysiological effects of propafenone, 5-hydroxy-propafenone, and N-depropylpropafenone on guinea pig ventricular muscle fibers

1 reference

12 December 2020

Beta-blocking effect of propafenone based on spectral analysis of heart rate variability

1 reference

12 December 2020

Premature ventricular complexes. Diagnosis and indications for therapy

1 reference

12 December 2020

European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias

1 reference

12 December 2020

Aggravation of electrically provoked ventricular tachycardia during treatment with propafenone.

1 reference

12 December 2020

Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone

1 reference

12 December 2020

The use of associated propafenone in patients with amiodarone-resistant ventricular tachycardia

1 reference

12 December 2020

Comparative pharmacokinetics and clinical pharmacology of propafenone enantiomers after oral administration to man

1 reference

12 December 2020

Oral propafenone therapy for children with arrhythmias: efficacy and adverse effects in midterm follow-up

1 reference

12 December 2020

Transfer of propafenone and 5-OH-propafenone to foetal plasma and maternal milk

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic interactions of propafenone and cimetidine

1 reference

12 December 2020

Negative inotropic effects of the new class I antiarrhythmic agents berlafenone and alprafenone on electrically stimulated isolated cardiomyocytes

1 reference

12 December 2020

Identification of propafenone metaboliser phenotype from plasma and urine excretion data.

1 reference

12 December 2020

Propafenone in the treatment of patients with malignant ventricular tachyarrhythmias.

1 reference

12 December 2020

[Emergency treatment of arrhythmias in neonates and infants]

1 reference

12 December 2020

Paroxysmal supraventricular tachycardia: experience with propafenone

1 reference

12 December 2020

Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy

1 reference

12 December 2020

Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies

1 reference

12 December 2020

Congestive heart failure induced by six of the newer antiarrhythmic drugs

1 reference

12 December 2020

Propafenone disposition kinetics in cardiac arrhythmia

1 reference

12 December 2020

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

12 December 2020

[Idiopathic ventricular tachyarrhythmia. Spontaneous variability and effect of various antiarrhythmic agents]

1 reference

12 December 2020

Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study

1 reference

12 December 2020

Determination of plasma protein binding of propafenone in rats, dogs and humans by highly sensitive gas chromatography-mass spectrometry

1 reference

12 December 2020

The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart

1 reference

12 December 2020

Usefulness of propafenone for recurrent paroxysmal atrial fibrillation

1 reference

12 December 2020

Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia

1 reference

12 December 2020

Electrophysiological and Antiarrhythmic Properties of Propafenon in Isolated Cardiac Preparations

1 reference

12 December 2020

Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency

1 reference

12 December 2020

[Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia]

1 reference

12 December 2020

Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease

1 reference

12 December 2020

The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation

1 reference

12 December 2020

1 reference

12 December 2020

Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study

1 reference

12 December 2020

Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapy.

1 reference

12 December 2020

Pharmacokinetics of oral propafenone in patients with supraventricular arrhythmia

1 reference

12 December 2020

Determination of propafenone in biological fluids by fused-silica capillary gas chromatography using electron-capture detection

1 reference

12 December 2020

Rate-dependent failure of ventricular capture in patients treated with oral propafenone

1 reference

12 December 2020

Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity

1 reference

12 December 2020

Electrophysiological effects of propafenone on isolated guinea-pig ventricular muscle and sheep Purkinje fibres

1 reference

12 December 2020

Cardioprotective effects of various class I antiarrhythmic drugs in canine hearts

1 reference

12 December 2020

Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences

1 reference

12 December 2020

Electrophysiological effects of 5-hydroxypropafenone on guinea pig ventricular muscle fibers.

1 reference

12 December 2020

Effects of Propafenone on Induction and Maintenance of Atrioventricular Nodal Reentrant Tachycardia

1 reference

12 December 2020

Electrophysiologic effects of intravenous propafenone in Wolff-Parkinson-White syndrome

1 reference

12 December 2020

Comparative Frequency-Dependent Effects of Three Class Ic Agents, Org 7797, F]ecanide, and Proprafenone, on ventricular Action Potential Duration

1 reference

12 December 2020

Treatment of ventricular arrhythmias by United States cardiologists: a survey before the cardiac arrhythmia suppression trial results were available

1 reference

12 December 2020

Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia

1 reference

12 December 2020

Symptomatic sinus node dysfunction associated with the use of propafenone

1 reference

12 December 2020

Propafenone in the treatment of chronic ventricular arrhythmias in a pregnant patient

1 reference

12 December 2020

Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial

1 reference

12 December 2020

Short- and long-term effects of propafenone in ventricular arrhythmias

1 reference

12 December 2020

Propafenone and 5-hydroxypropafenone concentrations in the right atrium of patients undergoing heart surgery

1 reference

12 December 2020

Liquid chromatographic analysis of propafenone enantiomers in human plasma

1 reference

12 December 2020

Propafenone, a review of its profile

1 reference

12 December 2020

Exacerbation of myasthenia by propafenone

1 reference

12 December 2020

Raised serum levels of desipramine with the antiarrhythmic propafenone

1 reference

12 December 2020

Food increases the bioavailability of propafenone

1 reference

12 December 2020

Management of atrial fibrillation

1 reference

12 December 2020

Propafenone for prevention of recurrent atrial fibrillation

1 reference

12 December 2020

Symptomatic hyponatremia related to the use of propafenone

1 reference

12 December 2020

[Effects of propafenone on arrhythmias induced by exertion in patients with ischemic cardiopathy]

1 reference

12 December 2020

Pharmacologic management of ventricular arrhythmias after the cardiac arrhythmia suppression trial

1 reference

12 December 2020

Intravenous administration of propafenone

1 reference

12 December 2020

[Efficacy of propafenone in the treatment of ventricular hyperkinetic arrhythmias in subjects with a history of myocardial infarction]

1 reference

12 December 2020

[Digoxin-propafenone interaction: values and limitations of plasma determination of the 2 drugs. Anti-arrhythmia effectiveness of propafenone]

1 reference

12 December 2020

A receptor for type I antiarrhythmic drugs associated with rat cardiac sodium channels

1 reference

12 December 2020

Electrophysiological mechanism for the antiarrhythmic action of propafenone: a comparison with mexiletine

1 reference

12 December 2020

The Relative Potency of Major Metabolites and Enantiomers of Propafenone in an Experimental Reperfusion Arrhythmia Model

1 reference

12 December 2020

Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia

1 reference

12 December 2020

The multiple modes of action of propafenone

1 reference

12 December 2020

Propafenone disposition in renal insufficiency and renal failure

1 reference

12 December 2020

Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG).

1 reference

12 December 2020

Changes in cardiac output determined by continuous-wave Doppler echocardiography during propafenone or mexiletine drug testing

1 reference

12 December 2020

The management of patients with life-threatening ventricular tachyarrhythmias: programmed stimulation or Holter monitoring (either or both)?

1 reference

12 December 2020

Antiarrhythmic efficacy of propafenone: evaluation of effective plasma levels following single and multiple doses

1 reference

12 December 2020

Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of mexiletine in patients with ventricular tachycardia

1 reference

12 December 2020

Propafenone in the prevention of non-ventricular arrhythmias associated with the Wolff-Parkinson-White syndrome

1 reference

12 December 2020

d-Sotalol has opposite effects from encainide and propafenone on the proportion of episodes of ventricular tachycardia that are sustained in an experimental substrate for reentry.

1 reference

12 December 2020

Interaction between warfarin and propafenone in healthy volunteer subjects

1 reference

12 December 2020

Effects of coadministration of propafenone on the pharmacokinetics of digoxin in healthy volunteer subjects

1 reference

12 December 2020

Therapeutic efficacy and safety of oral propafenone for atrial fibrillation

1 reference

12 December 2020

Propafenone and a syndrome of the lupus erythematosus type

1 reference

12 December 2020

Propafenone--a new antiarrhythmic drug

1 reference

12 December 2020

Atrial flutter in patients treated for atrial fibrillation with propafenone

1 reference

12 December 2020

Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect

1 reference

12 December 2020

Effects of propafenone on 45Ca movements and contractile responses in vascular smooth muscle

1 reference

12 December 2020

Comparison of the pharmacodynamic effects of intravenous and oral propafenone

1 reference

12 December 2020

[Therapy of severe propafenone poisoning--an attempt at elimination by hemoperfusion]

1 reference

12 December 2020

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

12 December 2020

[Treatment of recent atrial fibrillation with intravenous propafenone]

1 reference

12 December 2020

Electrophysiologic effects of propafenone on canine ischemic cardiac cells

1 reference

12 December 2020

Propafenone for paroxysmal atrial fibrillation

1 reference

12 December 2020

1 reference

12 December 2020

Plasma and saliva propafenone concentrations at steady state

1 reference

12 December 2020

Theophylline toxicity after propafenone treatment: evidence for drug interaction

1 reference

12 December 2020

Atrial automatic tachycardia in children

1 reference

12 December 2020

Definition of benign versus malignant ventricular arrhythmias: Targets for treatment

1 reference

12 December 2020

Effects of mexiletine, propafenone and flecainide on signal-averaged electrocardiogram

1 reference

12 December 2020

Enhanced antiarrhythmic efficacy of propafenone when used in combination with procainamide or quinidine.

1 reference

12 December 2020

Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias

1 reference

12 December 2020

Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up

1 reference

12 December 2020

The electrophysiologic effects of propafenone hydrochloride in the neonatal canine

1 reference

12 December 2020

Propafenone: an antiarrhythmic come in from the cold

1 reference

12 December 2020

Comparison of the efficacy/tolerability ratio of cibenzoline and propafenone in the treatment of ventricular arrhythmia

1 reference

12 December 2020

Potassium channel blocking properties of propafenone in rabbit atrial myocytes

1 reference

12 December 2020

Stereoselective interactions of (R)- and (S)-propafenone with the cardiac sodium channel

1 reference

12 December 2020

Beta blockers in combination with class I antiarrhythmic agents

1 reference

12 December 2020

The ESVEM trial. Electrophysiologic Study Versus Electrocardiographic Monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. The ESVEM Investigators

1 reference

12 December 2020

Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases

1 reference

12 December 2020

Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length

1 reference

12 December 2020

Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset

1 reference

12 December 2020

In vitro testing of triamterene derivatives for antiarrhythmic activity

1 reference

12 December 2020

Propafenone for cardiac arrhythmias

1 reference

12 December 2020

Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmias

1 reference

12 December 2020

Clinical pharmacology of propafenone

1 reference

12 December 2020

Differential analysis of the frequency-dependent effects of class 1 antiarrhythmic drugs according to periodical ligand binding: implications for antiarrhythmic and proarrhythmic efficacy

1 reference

12 December 2020

The proarrhythmic effects of antiarrhythmic drugs

1 reference

12 December 2020

Identification of antiarrhythmic drugs and their metabolites in urine

1 reference

12 December 2020

Pharmacokinetics of intravenous propafenone in patients with episodes of paroxysmal supraventricular tachycardia

1 reference

12 December 2020

The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmia

1 reference

12 December 2020

The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

1 reference

12 December 2020

Apparent stereoselectivity in propafenone uptake by human and rat erythrocytes

1 reference

12 December 2020

Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure.

1 reference

12 December 2020

Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience

1 reference

12 December 2020

Efficacy of oral propafenone in chronic ventricular arrhythmias: a placebo controlled cross-over exercise study

1 reference

12 December 2020

Long term inotropic effects of flecainide and propafenone

1 reference

12 December 2020

Direct separation of the enantiomers of propafenone, diprafenone and their major metabolites by high-performance liquid chromatography on modified cellulose and amylose chiral stationary phases

1 reference

12 December 2020

Effect of propafenone in patients with stable ventricular arrhythmias

1 reference

12 December 2020

Interaction between propranolol and propafenone in healthy volunteers

1 reference

12 December 2020

Influence of hepatic dysfunction on the pharmacokinetics of propafenone.

1 reference

12 December 2020

[Efficacy of intravenous and per os propafenone in the ambulatory treatment of recent-onset atrial fibrillation]

1 reference

12 December 2020

Plasma propafenone concentration in the evaluation of anti-arrhythmic efficacy

1 reference

12 December 2020

Ciclosporin-propafenone interaction

1 reference

12 December 2020

Acute effects of intravenous propafenone on the internal ventricular defibrillation threshold in the anesthetized dog

1 reference

12 December 2020

Effect of propafenone hydrochloride on lymphocyte membrane beta 2 adrenoceptors in ventricular arrhythmias

1 reference

12 December 2020

Clinical pharmacokinetics of propafenone

1 reference

12 December 2020

1 reference

12 December 2020

Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dysrhythmias

1 reference

12 December 2020

Propafenone for malignant ventricular arrhythmia: an analysis of the literature

1 reference

12 December 2020

Inhibiton of $$\dot V_{\max } $$ of the action potential by propafenone and its voltage-, time- and pH-dependence in mammalian ventricular myocardium

1 reference

12 December 2020

Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol.

1 reference

12 December 2020

HPLC determination of 5-hydroxypropafenone in plasma with electrochemical detection

1 reference

12 December 2020

[Pharmacologic cardioversion with propafenone of stable atrial fibrillation of recent onset]

1 reference

12 December 2020

Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap.

1 reference

12 December 2020

Effects of Org 7797 on early, late and inducible arrythmias following coronary artery occlusion in rats and dogs

1 reference

12 December 2020

Interaction between digoxin and propafenone

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group

1 reference

12 December 2020

Effects of propafenone on sinus nodal and ventricular automaticity: in vitro and in vivo correlation

1 reference

12 December 2020

Efficacy of intravenous propafenone in acute atrial fibrillation complicating open-heart surgery.

1 reference

12 December 2020

Intrauterine therapy of fetal tachyarrhythmias: intraperitoneal administration of antiarrhythmic drugs to the fetus in fetal tachyarrhythmias with severe hydrops fetalis

1 reference

12 December 2020

Drug interaction between propafenone and metoprolol

1 reference

12 December 2020

Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter

1 reference

12 December 2020

Evaluation and treatment of ventricular arrhythmias: an update

1 reference

12 December 2020

Interaction between digoxin and propafenone in children

1 reference

12 December 2020

Tonic and phasic INa blockade by antiarrhythmics. Different properties of drug binding to fast sodium channels as judged from Vmax studies with propafenone and derivatives in mammalian ventricular myocardium

1 reference

12 December 2020

[Therapy of ventricular arrhythmias with propafenone]

1 reference

12 December 2020

Pharmacokinetics of propafenone enantiomers in rats.

1 reference

12 December 2020

Propafenone disposition and pharmacodynamics in normal and norepinephrine-induced cardiomyopathic rabbit hearts

1 reference

12 December 2020

Hemodialysis removal of propafenone

1 reference

12 December 2020

Serum digoxin levels related to plasma propafenone levels during concomitant treatment

1 reference

12 December 2020

The efficacy of propafenone on exercise-induced ventricular arrhythmias

1 reference

12 December 2020

Electrophysiologic effects of intravenous propafenone at rest, during isoproterenol infusion and during exercise in the Wolff-Parkinson-White syndrome

1 reference

12 December 2020

In vitro protein binding of propafenone in normal and uraemic human sera

1 reference

12 December 2020

Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up

1 reference

12 December 2020

A comparison of antiarrhythmic drugs for the suppression of ventricular ectopic depolarizations: A meta-analysis

1 reference

12 December 2020

Wolff-Parkinson-White syndrome. Identification and management

1 reference

12 December 2020

Rifampicin lowers plasma concentrations of propafenone and its antiarrhythmic effect.

1 reference

12 December 2020

Evaluation of the asthmogenicity of propafenone, a new antiarrhythmic drug. Comparison of spirometry with methacholine challenge

1 reference

12 December 2020

Daily reproducibility of electrophysiologic test results in malignant ventricular arrhythmia

1 reference

12 December 2020

Antiarrhythmic effects of two new propafenone related drugs. A study on four animal models of arrhythmia.

1 reference

12 December 2020

Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias

1 reference

12 December 2020

Mechanism of antiarrhythmic efficacy of propafenone as assessed by programmed electrical stimulation in conscious dogs

1 reference

12 December 2020

[Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole]

1 reference

12 December 2020

A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes

1 reference

12 December 2020

Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation

1 reference

12 December 2020

Usefulness of intravenous propafenone for control of postoperative junctional ectopic tachycardia

1 reference

12 December 2020

Effects of class I drugs on reentrant ventricular tachycardia in a canine model of myocardial infarction. On their antiarrhythmic and proarrhythmic mechanisms

1 reference

12 December 2020

Antiarrhythmic and electrophysiologic effects of oral propafenone

1 reference

12 December 2020

Comparative evaluation of verapamil, flecainide and propafenone for the acute conversion of atrial fibrillation to sinus rhythm

1 reference

12 December 2020

Propafenone associated agranulocytosis

1 reference

12 December 2020

Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies

1 reference

12 December 2020

Acute and long-term efficacy of oral propafenone in patients with ventricular tachyarrhythmias

1 reference

12 December 2020

Propafenone: noninvasive evaluation of efficacy

1 reference

12 December 2020

Oral propafenone therapy for patients with paroxysmal supraventricular tachyarrhythmia

1 reference

12 December 2020

Self-poisoning with propafenone. Apropos of a case

1 reference

12 December 2020

A comparative evaluation of the effects of propafenone and lidocaine on early ventricular arrhythmias after acute myocardial infarction.

1 reference

12 December 2020

Oral propafenone in refractory arrhythmia. Apropos of 68 patients

1 reference

12 December 2020

Propafenone versus disopyramide for treatment of chronic symptomatic ventricular arrhythmias. A multicenter study

1 reference

12 December 2020

Propafenone treatment of recurrent ventricular tachycardia: comparison of continuous electrocardiographic recording and electrophysiologic study in predicting drug efficacy

1 reference

12 December 2020

[Anti-arrhythmia efficacy of propafenone per os in the prevention of paroxysmal supraventricular arrhythmia resistant to class Ia agents]

1 reference

12 December 2020

Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents.

1 reference

12 December 2020

Block of sodium currents by antiarrhythmic agents: Analysis of the electrophysiologic effects of propafenone in heart muscle

1 reference

12 December 2020

Restoration of sinus rhythm in atrial fibrillation of recent onset using intravenous propafenone

1 reference

12 December 2020

Stereoselective disposition and pharmacologic activity of propafenone enantiomers

1 reference

12 December 2020

Effects of propafenone on electrical and mechanical activities of single ventricular myocytes isolated from guinea-pig hearts

1 reference

12 December 2020

In vitro characterization of the human cytochrome P-450 involved in polymorphic oxidation of propafenone

1 reference

12 December 2020

Determination of 5-hydroxypropafenone in biological fluids by fused-silica capillary gas chromatography using electron-capture detection

1 reference

12 December 2020

The 'Sicilian Gambit'. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology

1 reference

12 December 2020

Acute and long-term efficacy of propafenone in patients with sustained ventricular tachyarrhythmias: assessment with programmed ventricular stimulation

1 reference

12 December 2020

Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time

1 reference

12 December 2020

Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism

1 reference

12 December 2020

Significance of the degree of oxidative hepatic metabolism in conditioning the pharmacokinetics and the pharmacodynamics of propafenone

1 reference

12 December 2020

Nonlinear kinetics of propafenone metabolites in healthy man

1 reference

12 December 2020

Electrophysiologic effects of Org 7797, a new steroidal antiarrhythmic agent: comparison with class 1a, 1b, and 1c drugs

1 reference

12 December 2020

Propafenone ingestion

1 reference

12 December 2020

Propafenone versus disopyramide: a double-blind randomized crossover trial in patients presenting chronic ventricular arrhythmias

1 reference

12 December 2020

Clinical course and outcome in class IC antiarrhythmic overdose

1 reference

12 December 2020

Effects of propafenone on directly measured sinoatrial conduction time

1 reference

12 December 2020

Efficacy and safety of propafenone in congenital junctional ectopic tachycardia

1 reference

12 December 2020

Antiarrhythmic drug therapy for suppression of ventricular arrhythmia: experience with 122 patients treated for two years

1 reference

12 December 2020

Hemodynamic effects of antiarrhythmic drugs: negative inotropy versus influence on peripheral circulation.

1 reference

12 December 2020

Efficacy of intravenous propafenone for the acute management of atrial fibrillation

1 reference

12 December 2020

Effects of acute and prolonged administration of propafenone on internal defibrillation in the pig

1 reference

12 December 2020

Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias

1 reference

12 December 2020

High-performance liquid chromatographic determination of 12 antiarrhythmic drugs in plasma using solid-phase column extraction

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of propafenone during acute and chronic administration

1 reference

12 December 2020

Electrophysiologic interactions between mexiletine and propafenone in guinea pig papillary muscles

1 reference

12 December 2020

[Long-term study of propafenone in severe ventricular extrasystole in elderly subjects]

1 reference

12 December 2020

Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia

1 reference

12 December 2020

Potentiation of the anticoagulant effect of fluindione by propafenone

1 reference

12 December 2020

Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia

1 reference

12 December 2020

Intravenous propafenone reduces energy requirements for defibrillation in pigs

1 reference

12 December 2020

Identification and determination of propafenone and its principal metabolites in human urine using capillary gas chromatography/mass spectrometry

1 reference

12 December 2020

Randomized placebo-controlled trial of propafenone for treatment of atrial tachyarrhythmias after cardiac surgery

1 reference

12 December 2020

Short-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients with symptoms

1 reference

12 December 2020

Developmental electrophysiologic effects of propafenone and 5-hydroxypropafenone on the canine cardiac Purkinje fiber.

1 reference

12 December 2020

Diprafenone--comparative study of anti-arrhythmia therapy with propafenone

1 reference

12 December 2020

Investigations on the pharmacokinetics of propafenone in man

1 reference

12 December 2020

A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.)

1 reference

12 December 2020

A Comparison of Intravenous Propafenone and Flecainide in the Treatment of Tachycardias Associated with the Wolff-Parkinson-White Syndrome

1 reference

12 December 2020

Long term efficacy of propafenone for prevention of atrial fibrillation

1 reference

12 December 2020

The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone

1 reference

12 December 2020

Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibers

1 reference

12 December 2020

Effects of propafenone on sinus node function in the rabbit heart

1 reference

12 December 2020

Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone

1 reference

12 December 2020

10.2165/00003495-199345010-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference